Fernando Ovalle (he/him) is an Endocrinologist in Birmingham, AL with over 15 years of experience. What is your opinion of Fernando Ovalle? Rate this provider below so other people can make informed decision.
Over 15 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Fernando Ovalle has received over $313,463 which includes payments from the following companies:
$146,793.83 from Novo Nordisk Inc
$95,274.31 from Janssen Pharmaceuticals, Inc
$17,704.41 from LILLY USA, LLC
$14,647.56 from sanofi-aventis U.S. LLC
$9,150.84 from Bayer HealthCare Pharmaceuticals Inc.
$4,801.13 from GlaxoSmithKline, LLC.
$4,665.37 from AstraZeneca Pharmaceuticals LP
$4,455.48 from Gilead Sciences Inc
$4,214.29 from Novo Nordisk AS
$3,618.44 from Corcept Therapeutics
$3,574.46 from Merck Sharp & Dohme Corporation
$1,358.68 from Medtronic MiniMed, Inc.
$844.55 from Aegerion Pharmaceuticals, Inc.
$548.49 from Becton, Dickinson and Company
$400.00 from Tandem Diabetes Care, Inc.
$300.00 from Intuitive Surgical, Inc.
$285.00 from UCB SA
$277.32 from Janssen Scientific Affairs, LLC
$208.56 from Amgen Inc.
$124.99 from Janssen Research & Development, LLC
Payments received by Fernando Ovalle were from the following categories:
$197,100.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!